Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.47
Delayed Data
As of 12:49pm ET
 0.00 / 0.00%
Today’s Change
0.46
Today|||52-Week Range
2.80
-61.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2011
Quarter 4
2011
Quarter 1
2012
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line4.5M-9.6M-6.9M--
 
 
 
 
Depreciation19.0K19.0K19.0K--
 
 
 
 
Total Other Cash Flow-8.3M2.0M1.8M--
 
 
 
 
Funds From Operations-3.8M-7.6M-5.1M--
 
 
 
 
Funds From/For Other Operating Expenses2.4M-3.2M2.3M--
 
 
 
 
Net Cash Flow - Operating Activities-6.2M-4.4M-7.4M--
 
 
 
 
 
InvestingIncrease In Investments-16.4M-14.6M-41.7M--
 
 
 
 
Decrease In Investments17.3M31.8M23.7M--
 
 
 
 
Capital Expenditures-8.0K-3.0K0.00--
 
 
 
Net Cash Flow Investing886.0K17.2M-18.1M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale122.0K6.0K53.8M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing122.0K6.0K53.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash31.0K15.0K-2.0K--
 
 
 
 
 
Net Change In Cash-5.2M12.8M28.3M0.00